Eduardo Dunayevich

Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Frank L. Greenway, Ken Fujioka, Raymond A Plodkowski et al. · The Lancet · 2010 · 991 citations

Obesity, Metabolic Syndrome, Non-pharmacological Intervention +9

A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity‐related risk factors (COR‐II)

Caroline M. Apovian, Louis J. Aronne, Domenica Rubino et al. · Obesity · 2013 · 688 citations · Full text

Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR‐BMOD Trial

Thomas A. Wadden, John P. Foreyt, Gary D. Foster et al. · Obesity · 2010 · 532 citations · Full text

Rational Design of a Combination Medication for the Treatment of Obesity

Frank L. Greenway, M.J. Whitehouse, Maria Guttadauria et al. · Obesity · 2008 · 342 citations · Full text

Bariatric Surgery, Combination Medication, Pharmacotherapy +24

Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trial

James T. Hartford, Susan G. Kornstein, Michael R. Liebowitz et al. · International Clinical Psychopharmacology · 2007 · 286 citations

Psychotropic Medication, Psychopharmacology, Pharmacotherapy +20